[Efficacy of infliximab in the treatment of follicular occlusion triad].
BACKGROUND
Dermatological treatments for the follicular occlusion triad have only partial and transient efficacy.


METHODS
A 20-year-old patient presented folliculitis of the scalp, acne and hidradenitis suppurativa, associated with spondyloarthritis. Treatment with infliximab for rheumatologic symptoms induced complete and lasting dermatological and rheumatological remission.


CONCLUSIONS
The efficacy of anti-TNF-alpha in follicular occlusion triad provided confirmation that infection is not at the heart of the aetiological process. However, efficacy data is still sparse and additional studies are required.
Deschamps
M-E
ME
Service de dermatologie, Hôtel-Dieu, CHU, université Clermont-Ferrand-1, boulevard Léon-Malfreyt, 63068 Clermont-Ferrand cedex 1, France. marie.deschamps1@free.fr
Payet
S
S
Tournadre
A
A
Soubrier
M
M
Souteyrand
P
P
D'Incan
M
M
D000152:Acne Vulgaris / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002481:Cellulitis / Q000188:drug therapy; D005499:Folliculitis / Q000188:drug therapy*; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D012074:Remission Induction; D013166:Spondylitis / Q000188:drug therapy*; D013577:Syndrome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab